BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• EXCELLENT CLINICAL DATA FOR SUBB2M/CA15-3 BREAST CANCER TEST

  INOVIQ Limited (ASX:IIQ) (INOVIQ or the Company), a developer of next-generation exosome solutions and precision diagnostics, is pleased to announce excellent results from an independent clinical validation study of its SubB2M/CA15-3 test for breast cancer detection.

  June 27, 2023

   · 

  9 min read
• Drug Development

  Intergalactic Therapeutics Announces Positive Results for Its Non-Viral Gene Therapy Platform in ABCA4 Retinopathies in Non-Human Primates

  Intergalactic Therapeutics today announced positive preclinical data from IG-002, its lead program addressing all forms of ABCA4-related retinopathies.

  June 27, 2023

   · 

  4 min read
• Drug Development

  Harpoon Therapeutics Announces Completion of Planned Patient Enrollment in Phase 1 Study of HPN217 in Relapsed/Refractory Multiple Myeloma

  Harpoon Therapeutics, Inc. today announced the completion of planned patient enrollment in the Phase 1 dose escalation study evaluating the safety, tolerability, and pharmacokinetics of HPN217 in patients with relapsed/refractory multiple myeloma.

  June 27, 2023

   · 

  5 min read
• Business

  CENTOGENE and Lifera, a Biopharma Company Owned by the PIF, Enter Strategic Collaboration

  CENTOGENE N.V. and Lifera today announced a strategic collaboration with the formation of a Joint Venture (JV) to increase local and regional access and rapid delivery of world-class multiomic testing to patients in Saudi Arabia and countries of the Gulf Cooperation Council (GCC).

  June 27, 2023

   · 

  9 min read
• Business

  Cybin Announces Appointment of Sanford R. Climan as Strategic Advisor

  Cybin Inc. is pleased to announce that Mr. Sanford R. Climan has joined Cybin as a strategic advisor.

  June 27, 2023

   · 

  7 min read
• Covalon Announces Participation in Oley Conference in St. Louis, Missouri on June 27 – 30, 2023

  Covalon Announces Participation in Oley Conference in St. Louis, Missouri on June 27 – 30, 2023.

  June 27, 2023

   · 

  7 min read
• Pharm Country

  Organon Publishes FY2022 ESG Report Showcasing Progress Toward Global Sustainability Goals

  Organon (NYSE: OGN), a global healthcare company focused on women’s health, today released its 2022-2023 Environmental, Social, and Governance (ESG) Report.

  June 27, 2023

   · 

  4 min read
• Drug Development

  Lobe Sciences Initiates Phase 1 Clinical Trial of L-130

  Lobe Sciences Ltd. today announced the initiation of a Phase 1, pharmacokinetic clinical study of L-130, a proprietary stabilized psilocin analogue drug candidate in healthy volunteers.

  June 27, 2023

   · 

  5 min read
• Business

  Windtree Therapeutics Appoints Mark Strobeck, Ph.D. to Board of Directors

  Windtree Therapeutics, Inc. today announced that the Company appointed Mark Strobeck, Ph.D. to its Board of Directors.

  June 27, 2023

   · 

  5 min read
• FDA

  FDA Approves BriaCell’s Pivotal Registrational Study Design in Advanced Metastatic Breast Cancer

  BriaCell Therapeutics Corp. announces that it has received approval from FDA on its pivotal registrational study design for Bria-IMT™ in combination with a checkpoint inhibitor in advanced metastatic breast cancer.

  June 27, 2023

   · 

  4 min read